CBG vs CBN: What's the Difference?
By Todd Smith, Co-Founder of Joy Organics

CBG (cannabigerol) and CBN (cannabinol) are both minor cannabinoids found in hemp, and both are non-intoxicating at the concentrations used in commercial products. But they come from different places in the plant's chemistry, have different research profiles, and are being studied for different potential applications. If you're trying to decide between a CBG product and a CBN product — or wondering whether a combination makes sense — this guide breaks it down.
What Is CBG?
CBG is cannabigerol, often called the "mother cannabinoid" because the hemp plant uses it as a chemical precursor to produce CBD, THC, and most other cannabinoids. It's present in small concentrations in mature hemp plants because most of it has already been converted into other compounds by harvest time. This rarity makes CBG products more expensive per milligram than CBD.
CBG interacts with CB1 and CB2 receptors in the body's endocannabinoid system (ECS) more directly than CBD does. Early research has looked at CBG in relation to neuroprotection, antibacterial activity, eye pressure, and appetite regulation. It's non-intoxicating at any dose.
What Is CBN?
CBN is cannabinol, and it forms differently than most cannabinoids. Rather than being synthesized directly by the plant, CBN is produced when THC degrades — through exposure to heat, light, or oxygen over time, a process known as THC degradation or THC aging. This is why older cannabis and hemp material tends to have higher CBN content than freshly harvested plant material.
CBN is present in very small amounts in fresh hemp and is typically found in higher concentrations in aged or oxidized plant matter. Like CBG, it's non-intoxicating at the concentrations used in commercial products, though very high doses of CBN in isolation have shown mild psychoactive effects in older research, interacting with cannabinoid receptors and the central nervous system.
CBN's most prominent area of study in modern wellness research is sleep. It's frequently combined with CBD in sleep-specific products, and Joy Organics' CBD Sleep Gummies include CBN as a key ingredient alongside CBD and trace THC for this reason.Â
See CBD Sleep Gummies with CBN →
How CBG and CBN Form: A Key Difference
Understanding where each cannabinoid comes from helps clarify their roles:
CBG (cannabigerol): Produced early in the plant's life as CBGA (cannabigerolic acid), the parent molecule and precursor to all major cannabinoids. As the young hemp plant matures, CBGA converts into CBDA (precursor to CBD), THCA (precursor to THC, the psychoactive cannabinoid), and other plant compounds. CBG is what remains when this conversion doesn't fully complete, highlighting the CBG vs CBN difference in their origin within the same plant.
CBN (cannabinol): Produced through the degradation of THC after harvest. When THC is exposed to air, heat, or UV light over time, it oxidizes into CBN. CBN is not directly produced by the living plant in significant quantities — it's essentially a breakdown product.
This means CBG and CBN represent opposite ends of the cannabinoid timeline: CBG is a starting point, CBN is an endpoint, illustrating how different cannabinoids affect our body at various stages.
How They Interact with the Body
Both CBG and CBN interact with the endocannabinoid system, but through different mechanisms.
CBG binds directly to CB1 and CB2 receptors in the body's endocannabinoid system (ECS). Some research suggests it may also influence GABA reuptake and alpha-2 adrenoceptors, pathways associated with the body's stress response and nervous system regulation. [1]
CBN has a moderate affinity for CB2 receptors and a lower affinity for CB1 receptors. It also interacts with TRP channels (transient receptor potential channels), which play a role in sensory signaling and inflammation response. [2] CBN is structurally similar to THC but binds to CB1 receptors much more weakly, which is why it doesn't produce the intoxication associated with THC.
CBG vs CBN: What Research Shows
CBG Research Areas
CBG research is still early-stage and primarily preclinical. Key areas include:
-
Neuroprotection: A 2015 study found CBG protected neurons in a mouse model of Huntington's disease. [3]
-
Antibacterial activity: A 2020 study found CBG effective against MRSA (antibiotic-resistant bacteria). [4]
-
Appetite support: A 2016 rodent study found CBG significantly increased food intake. [5]
-
Eye pressure: Preclinical research suggests cannabinoids, including CBG, may reduce intraocular pressure.
CBN Research Areas
CBN's research profile is also predominantly preclinical, but the focus areas are different:
-
Sleep and sedation: Older research (1970s) suggested CBN produced sedative effects in combination with THC. More recent research is investigating CBN's sleep-related mechanisms more rigorously.
-
Inflammation support: CBN has shown anti-inflammatory properties in preclinical models, potentially through both CB2 receptor and TRP channel interactions.
-
Appetite regulation: Like CBG, CBN has shown appetite-stimulating effects in rodent studies.
-
Antibacterial activity: CBN has also demonstrated antibacterial properties in preliminary research, including against MRSA strains.
Important: Both bodies of research are in early stages, conducted primarily in animal models or cell cultures. Neither CBG nor CBN is an FDA-approved treatment for any condition. These products are not intended to diagnose, treat, or cure any disease.
CBG vs CBN: Key Differences at a Glance
| CBG | CBN | |
|---|---|---|
|
Full name |
Cannabigerol |
Cannabinol |
|
Origin in the plant |
Precursor (converts into CBD, THC, etc.) |
Degradation product of THC |
|
Abundance in fresh hemp |
Very low (<1%) |
Very low |
|
Primary research focus |
Neuroprotection, antibacterial, appetite |
Sleep, inflammation, antibacterial |
|
Receptor interaction |
CB1 + CB2 (direct binding) |
CB2 (moderate), CB1 (weak) |
|
Intoxicating? |
No |
No (at commercial doses) |
|
Common product formats |
Tinctures, some gummies |
Sleep gummies, tinctures |
|
Typical use timing |
Morning or daytime |
Evening / sleep support |
Which Is Better for Sleep — CBG or CBN?
Based on available evidence, CBN is a more studied option for sleep support. Its research lineage in sleep dates to the 1970s, and it's the cannabinoid most commonly formulated into sleep-specific products alongside CBD. Joy Organics' CBD Sleep Gummies contain CBN alongside CBD and trace THC for precisely this reason, leveraging the entourage effect where all the cannabinoids interact to enhance wellness benefits.
CBG's appetite-stimulating effects in animal research actually suggest it may be better suited to daytime use for most people, though individual responses vary and no human clinical data has established firm timing recommendations.
If sleep support is your primary goal, a CBN + CBD product is the more targeted choice. If you're interested in CBG for daytime wellness support, a CBG + CBD tincture is the more relevant format to support mental clarity and daytime energy.
Shop CBD Sleep Gummies with CBN →
Can You Take CBG and CBN Together?
Yes. Some full spectrum hemp products contain both CBG and CBN alongside CBD and trace THC. There are no known safety concerns with using CBG and CBN together.
The rationale for combining them follows the entourage effect hypothesis — the idea that cannabinoids work more effectively in combination than in isolation because they engage the endocannabinoid system through different mechanisms simultaneously.
If you take prescription medications (like ones to manage stress, for chronic pain relief, or anxiety disorders), consult a healthcare professional before adding any cannabinoid product to your routine, as cannabinoids may influence how the liver processes certain drugs.
What About CBC? (CBG vs CBC)
Since searches for "cbc vs cbg" also lead people here, a brief note: CBC (cannabichromene) is another minor cannabinoid that, like CBG, is produced from CBGA in the hemp plant. It's non-intoxicating and has been studied in the context of mood balance, neurogenesis, and anti-inflammatory response. CBC appears in trace amounts in full-spectrum hemp products. It's less commercially prominent than CBG or CBN and is rarely the primary cannabinoid in a product.
Frequently Asked Questions
Is CBG or CBN better?
Neither is universally "better" — they're studied for different applications. CBN has more research in sleep; CBG has more research in neuroprotection and antibacterial activity. Your choice should depend on your wellness goals. For sleep, CBN + CBD is the more targeted option. For daytime support, CBG + CBD is more relevant.
Neither is universally "better" — they're studied for different applications. CBN has more research in sleep; CBG has more research in neuroprotection, antibacterial activity, and supporting the immune system. Your choice should depend on your wellness goals and how your body responds to these and other cannabinoids. For sleep, CBN + CBD is the more targeted option. For daytime support, CBG + CBD is more relevant for daytime focus and maintaining balance.
Is CBN more sedating than CBG?
Based on existing research, yes. CBN's historical research profile is more associated with sedation (particularly in combination with THC), while CBG's preclinical data points toward appetite stimulation and neuroprotection, interacting with serotonin receptors and promoting relaxation. Neither has been definitively confirmed as a sleep aid in robust human clinical trials or systematic review.
What does CBN stand for?
CBN stands for cannabinol. It forms when THC degrades over time through exposure to heat, light, or oxygen.
Will CBG or CBN show up on a drug test?
CBG and CBN themselves are unlikely to trigger a positive drug test. However, if you're using a full-spectrum product that contains trace THC (under 0.3%), that THC can accumulate with regular use and may be detected by sensitive tests. If you are subject to drug testing, choose a THC-free broad-spectrum or isolate product, and consult your employer or testing guidelines.
Can you take CBG and CBN at the same time?
Yes. There are no known safety concerns with combining CBG and CBN. While some people may prefer using just one cannabinoid, some full spectrum products include both. As always, consult a healthcare provider if you take prescription medications.
The Bottom Line
CBG and CBN are distinct cannabinoids with different origins, different research profiles, and different typical applications. CBG is a daytime-oriented cannabinoid being studied for neuroprotection, antibacterial activity, and appetite support. CBN is more commonly formulated for sleep and evening use. Both are non-intoxicating at commercial doses and are found in trace amounts in full-spectrum hemp products.
If you're choosing between them, start with your goal. For sleep: CBN + CBD. For daytime wellness or if you're specifically interested in the CBG research profile: CBG + CBD tincture. Both are available in USDA certified organic formulas from Joy Organics.
Shop CBD Sleep Gummies with CBN →
These statements have not been evaluated by the Food and Drug Administration. CBG and CBN products are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before adding any new supplement to your routine.
Sources
-
Cascio MG, et al. "Evidence That the Plant Cannabinoid Cannabigerol Is a Highly Potent Alpha-2-Adrenoceptor Agonist." British Journal of Pharmacology. 2010;159(1):129–141. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823359/
-
Appendino G, et al. "Antibacterial Cannabinoids from Cannabis sativa." Journal of Natural Products. 2008;71(8):1427–1430. https://pubmed.ncbi.nlm.nih.gov/18681481/
-
Valdeolivas S, et al. "Neuroprotective Properties of Cannabigerol in Huntington's Disease." Neurotherapeutics. 2015;12(1):185–199. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322067/
-
Farha MA, et al. "Uncovering the Hidden Antibiotic Potential of Cannabis." ACS Infectious Diseases. 2020;6(3):338–346. https://pubs.acs.org/doi/10.1021/acsinfecdis.9b00419
-
Brierley DI, et al. "Cannabigerol is a Novel, Well-Tolerated Appetite Stimulant in Pre-Satiated Rats." Psychopharmacology. 2016;233(19-20):3603–3613. https://pubmed.ncbi.nlm.nih.gov/27563840/
